Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$12.80 USD
+0.45 (3.64%)
Updated Mar 28, 2024 12:49 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/4/24 |
---|---|
Current Quarter | -4.00 |
EPS Last Quarter | -4.07 |
Last EPS Surprise | -1.75% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -17.20 |
Next Year | -11.80 |
EPS (TTM) | -19.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.62M | 0.54M | 1.50M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -4.00 | NA | -17.20 | -11.80 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | -4.00 | NA | -17.20 | -11.80 |
High Estimate | -4.00 | NA | -17.20 | -11.80 |
Low Estimate | -4.00 | NA | -17.20 | -11.80 |
Year ago EPS | -5.00 | -5.20 | -57.80 | -17.20 |
Year over Year Growth Est. | 20.00% | NA | 70.24% | 31.40% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | -4.00 | NA | -17.20 | -11.80 |
7 Days Ago | -4.00 | NA | -17.20 | -11.80 |
30 Days Ago | -4.00 | NA | -17.20 | -11.80 |
60 Days Ago | -4.00 | NA | -17.20 | -11.80 |
90 Days Ago | -4.00 | NA | -17.20 | -11.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | -4.00 | NA | -17.20 | -11.80 |
Zacks Consensus Estimate | -4.00 | NA | -17.20 | -11.80 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.07 | -5.00 | -5.20 | -5.00 | NA |
Estimate | -4.00 | NA | NA | NA | NA |
Difference | -0.07 | NA | NA | NA | -0.07 |
Surprise | -1.75% | NA | NA | NA | -1.75% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more